GSK starts GBP450 million buyback tranche as EU approves Exdensur drug
(Alliance News) - GSK PLC on Tuesday announced the beginning of the fourth tranche of a GBP2 billion buyback programme, worth GBP450 million. Read More
| Price | 2,226.00p on 19-02-2026 at 19:35:09 |
|---|---|
| Change | -42.00p -1.85% |
| Buy | 2,225.00p |
| Sell | 2,224.00p |
| Last Trade: | Sell 66,201.00 at 2,237.43p |
| Day's Volume: | 12,562,351 |
| Last Close: | 2,226.00p |
| Open: | 2,252.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,216.00p - 2,264.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £89.34b |
| VWAP: | 2,238.18901p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 66,201 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 622 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 5,020 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 352,680 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 40,967 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 15,534 | 2,237.43p | SI Trade Suspected SELL Trade |
16:52:09 - 19-Feb-26 |
| Sell* | 963 | 2,226.00p | SI Trade Suspected SELL Trade |
16:49:31 - 19-Feb-26 |
| Sell* | 792 | 2,226.00p | SI Trade Suspected SELL Trade |
16:49:31 - 19-Feb-26 |
| Buy* | 15,330 | 2,252.50p | SI Trade Negotiated Trade |
16:48:15 - 19-Feb-26 |
| Buy* | 31,667 | 2,232.289p | SI Trade Negotiated Trade |
16:42:05 - 19-Feb-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 19th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 18th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 17th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 17th Feb 2026 7:00 am | RNS | GSK - fourth tranche of share buyback programme |
| 17th Feb 2026 7:00 am | RNS | Exdensur approved by the European Commission |
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |